CN
Home/About Us/News Center

Landing in the Chinese market


Doublisure Special Medical Purpose Infant Formula Debuts in the Chinese Market

Recently, Doublisure special medical purpose infant formula has officially debuted in the Chinese market, bringing new options for infants with special nutritional needs.

Special medical purpose infant formula is specifically designed to meet the nutritional requirements of infants with special diseases or physiological conditions. Doublisure's products have undergone strict research, development, and testing, and meet the relevant standards for special medical purpose formula foods in China. Aiming at infants with different needs, such as premature infants, low - birth - weight infants, and infants allergic or intolerant to certain nutrients, it provides precise nutritional support.

With the gradual development of the special medical food market in China, a large number of special medical infant formula products have been approved so far. The entry of Doublisure will further enrich the market and promote industry competition and innovation. This not only helps to meet the diverse needs of consumers, but also promotes the entire special medical purpose infant formula market to develop in a more professional and refined direction, safeguarding the healthy growth of more babies.


Related News

Newsletter

Subscribe to our newsletter and get exclusive offers, news & more.

Social Platform
Follow us and use the following social media platforms to get in contact with us
TCL中环长期专注于新能源光伏产业,主营业务围绕硅材料研发与制造展开
  1. 联系我们

地址:Level 4, 830 Whitehorse Rd, Box Hill VIC 3128

电话:1300 282 345 (Australia) +61 420 282 345 (overseas)

传真: 022-23789766

邮箱: info@nutrimores.com

微信公众号

Nutrimores Pty Ltd. All rights reserved. 2024